Hemorrhagic Cellulitis and Osteomyelitis Secondary to Ibrutinib Therapy

Am J Ther. 2021 Jan-Feb;28(1):e148-e150. doi: 10.1097/MJT.0000000000000979.

Authors

Ajay Tambe¹, Wajihuddin Syed², Muhammad Naqvi², Vikrant Tambe¹, Rachana Mandru¹

Affiliations

¹ Departments of Internal Medicine.
² Hematology/Oncology, SUNY Upstate Medical University, Syracuse, NY.

PMID: 33369917
DOI: 10.1097/MJT.0000000000000979

No abstract available

MeSH terms

Adenine / analogs & derivatives
Cellulitis* / chemically induced
Humans
Osteomyelitis* / drug therapy
Piperidines
Pyrazoles / adverse effects
Pyrimidines / adverse effects

Substances

Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine